Podcasts
Rest your eyes or use your commute time to learn. Listen to our experts discuss the hot topics that you need to track. And get a glimpse into the personalities behind the smiles.
Featured Content
Quality Measurement and Its Effect on Consumers
Listen to Avalere's Debbie Lucas explain the complex world of quality measurement.
Stakeholders Still Await Forthcoming ACO Rule
As stakeholders across the healthcare spectrum continue to wait for CMS’ ACOs Rule 2.0, Avalere’s Josh Seidman takes a crack at pinpointing the much anticipated ACO policy changes.
The Time Is Now for Accountable Care Organizations (ACOs)
With something as complex and as political as shared savings models in healthcare, there will always be push-back. But according to Avalere’s Josh Seidman, now is a unique opportunity for Accountable Care Organizations (ACOs) to finally succeed. Josh explains that the current healthcare infrastructure makes ACOs attainable thanks to recent changes, including increased electronic health record use, more provider comfort with comparative performance reporting, enhanced centrality of patient engagement and new incentives that reward accountability and value.
The Emerging Initiative of 21st Century Cures
Even during these gridlocked times in Congress, certain healthcare initiatives are getting through the cracks; one of these such initiatives is 21st Century Cures.
Quality Measurement and Its Effect on Providers
Listen to Debbie Lucas discuss how quality measurement can lead to improvements in the quality of care and the impact on providers.
Quality Measurement Is the Foundation for Improving Quality Care
The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.
What’s to Come in MolDx?
Meet Kathy Hughes who leads our Molecular Diagnostics team and has successfully advised device, diagnostics and pharmaceutical companies on optimal market access strategies for over a decade. Kathy addresses key evidentiary developments in the diagnostics space, and what she sees as the future of this evolving field.
Benchmark Survey Results
A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.
Understanding New Approaches to Medicaid Expansion
In this podcast, Matt Eyles, Executive Vice President of Health Plans and Providers, gives a short preview of his upcoming MHPA presentation, Medicaid Premium Assistance Programs: Opportunities and Challenges for States and Plans.